Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "myosin, light chain 12-like, regulatory pseudogene" is a non-protein-coding pseudogene related to the myosin light chain family. Unlike canonical myosin light chain proteins (such as MYL12A or MYL12B), this pseudogene does not produce a functional regulatory light chain subunit and does not directly participate in myosin-mediated contractile mechanics. Some myosin light chain-related pseudogenes can act in gene regulation by affecting the RNA stability or transcription of their parental genes, potentially impacting cellular processes such as proliferation. However, no evidence supports a direct therapeutic or biomarker role for this specific pseudogene (ENSG00000263199). Pseudogenes may sometimes be misclassified as protein-coding targets in large genomic datasets; careful curation is required to avoid such errors when selecting drug targets[2][4]. In summary, ENSG00000263199 represents a regulatory pseudogene, not a canonical therapeutic target[2][4]. If your intent is to study a druggable myosin light chain protein, targets such as MYL12A or MYL12B (protein-coding genes) should be used instead[6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Myosin, light chain 12-like, regulatory pseudogene.